MINDACT: Long-Term Results of the Large Prospective Trial Testing the 70-Gene Signature Mammaprint as Guidance for Adjuvant Chemotherapy in Breast Cancer Patients.
AuthID
P-00S-VCA
P-00S-VCA
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service